Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombocytopenia × eltrombopag × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 14 Other hematologic neoplasm 9 Myeloid 3 Lymphoid 3 Sarcoma 1 Plasma cell 1

Conditions

Sarcoma 2 Thrombocytopenia 1 Osteosarcoma 1 Neoplasms, Connective and Soft Tissue 1 Bone Neoplasms 1

Interventions

Thrombopoietin 2 eltrombopag 1 Temozolomide 1 Radiotherapy 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Comparative Genomic Hybridization 1 Carboplatin 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00358540 2017-11-13

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

GlaxoSmithKline

Phase 1 Completed

Classical hematologySarcoma

Sarcoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡